Coronary Stents Market in India 2014

Coronary Stents Market in India 2014


  • Products Id :- NS337
  • |
  • Pages: 136
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

This report will be delivered within 48 working hours of the purchase.

Executive Summary

Netscribes' latest market research report titled Coronary Stents Market in India 2014 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of reasons. With cardiovascular diseases becoming a common occurrence amongst Indians and the healthcare infrastructure in the country rapidly improving, the number of angioplasty procedures being carried out in the country has increased significantly. Advancements in technology has resulted in patients being more receptive towards stent implants. The products available in the market can be divided into two types-those manufactured by MNCs and commanding high prices, and those manufactured by domestic companies and generally having lower prices. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy whereas those manufactured by domestic companies fail to attain similar high quality. As a result, the MNCs serve majority of the market with almost all the big hospitals in tier I cities preferring to implant stents manufactured by foreign companies.

Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Slide 1: Executive Summary

Macroeconomic Indicators

Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013-Dec 2013)

Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013-Jul 2013), Exchange Rate: Half Yearly (Oct 2013-Mar 2014)

Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)

Introduction

Slide 5: Coronary stents-Uses, Characteristics and Types

Slide 6: Development of Coronary Stents

Market Overview

Slide 7: Angioplasties-Overview and Number of Procedures Performed in India (2008-2018e)

Slide 8: Angioplasties-Segmentation (Age-Wise; 2008-2013 & Gender-Wise; 2008 -2013)

Slide 9: Angioplasties-Segmentation (Based on Vessels Treated; 2009-2013 & Segregation of Centers Based on Number of Angioplasties Performed Each Year; 2009, 2010, 2011, 2013)

Slide 10: Coronary Stents-Market Overview, Market Size & Growth (Value-Wise; 2012-2018e & Volume-Wise; 2012-2018e)

Slide 11: Drug-Eluting Stents-Market Overview, Market Size & Growth (Value-Wise; 2012-2018e & Volume-Wise; 2012-2018e)

Slide 12: Bare Metal Stents-Market Overview, Market Size & Growth (Value-Wise; 2012-2018e & Volume-Wise; 2012-2018e)

Slide 13: Bioabsorbable Stents-Market Overview, Market Size & Growth (Value-Wise; 2013-2018e & Volume-Wise; 2013e-2018e)

Slide 14: Coronary Stents-Price Trends

Drivers & Challenges

Slide 15: Drivers and Challenges-Summary

Slide 16-20: Drivers

Slide 21-22: Challenges

Government Involvement

Slide 23: Organizational Structure of Regulatory Bodies

Slide 24-25: Regulatory Bodies

Slide 26-29: Regulatory Policies

Slide 30: Process of Obtaining License for Manufacturing Medical Device Regulated as Drugs in India

Slide 31-33: Requirements for Grant of License for Manufacture of Medical Devices in India

Slide 34: Process of Obtaining Registration for Import of Medical Device Regulated as Drugs in India

Slide 35-39: Documents Required for the Registering Medical Devices for Import into India

Competitive Landscape

Slide 40-42: Entry Barriers

Slide 43: Porter's Five Forces Analysis

Slide 44: Competition Overview, Market Share of Companies (Volume-Wise; 2013)

Slide 45: Sale of Coronary Stents by Various Companies (2013)

Slide 46-49: Competitive Benchmarking

Slide 50-98: Major Companies

Buyer Details

Slide 99: List of Top 10 Hospitals Buying Coronary Stents in India

Slide 100-129: Major Buyers

Slide 130: Other Major Purchasers of Stents

Recent Developments

Slide 131: Major Recent Developments in the Market

Strategic Recommendation

Slide 132-133: Key Recommendations

Slide 134: Opportunities by Geography

Appendix

Slide 135: Key Ratios Description

Slide 136: Sources of Information

Macro Economic Indicators

1. GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14)

2. Inflation Rate: Monthly (Jul-Aug 2013-Nov-Dec 2013)

3. Gross Fiscal Deficit: Monthly (Feb 2013-Jul 2013)

4. Exchange Rate: Monthly (Oct 2013-Mar 2014)

5. Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12)

6. Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14)

7. FDI Annual (2009-10, 2010-11, 2011-12, 2012-13)

Market Overview

1. Number of Angioplasty Procedures (2008-2018e)

2. Angioplasty-Segmentation (Age-Wise; 2008-2013)

3. Angioplasty-Segmentation (Gender-Wise; 2008-2013)

4. Angioplasty-Segmentation (Based on Vessels Treated; 2009-2013)

5. Segregation of Centers Based on Number of Angioplasties Performed Each Year (2009, 2010, 2011, 2013)

6. Coronary Stents-Market Size & Growth (Value-Wise; 2012-2018e)

7. Coronary Stents-Market Size & Growth (Volume-Wise; 2012-2018e)

8. Drug-Eluting Stents-Market Size & Growth (Value-Wise; 2012-2018e)

9. Drug-Eluting Stents-Market Size & Growth (Volume-Wise; 2012-2018e)

10. Bare Metal Stents-Market Size & Growth (Value-Wise; 2012-2018e)

11. Bare Metal Stents-Market Size & Growth (Volume-Wise; 2012-2018e)

12. Bioabsorbable Stents-Market Size & Growth (Value-Wise; 2013-2018e)

13. Bioabsorbable Stents-Market Size & Growth (Volume-Wise; 2013-2018e)

Drivers & Challenges

1. CVD Prevalence-Number of Patients (2012-2018e)

2. Diabetes Prevalence-Number of Patients (2012-2018e)

3. Budget Allocation of Funds for Healthcare Sector (2010-11-2014-15)

4. Private Hospitals Market in India (Value-Wise; 2012-2018e)

5. Population Above 60 Years (2012-2018e)

6. Average Life Expectancy (1990, 2000, 2010, 2011, 2012)

7. Household Expenditure-Share of Wallet % (2005, 2015e, 2025e)

Competitive Landscape

1. Market Share (Volume-Wise; 2013)

2. Competitive Benchmarking-Key Ratios of Top 3 Companies-Operational & Financial Basis (FY2013)

3. Company Profiles (All Companies)

a. Ownership Structure (Private Companies)

b. Financial Snapshot (except Boston Scientific India Pvt. Ltd.)

c. Key Business segments (Public Companies)

d. Key Geographic segments (Public Companies)

Market Overview

1. Coronary Stents-Price Trends

Government Involvement

1. Reimbursement Rates Under Central Government Health Scheme (2007, 2011, 2013)

Competitive Landscape

1. Coronary Stents Sale (Company-Wise; 2013)

2. Company Profiles (All Companies)

a. Company Information (All Companies)

b. Products and Services (All Companies)

c. Key People (All Companies)

d. Shareholders of the Company (Private Companies)

e. Key Financial Performance Indicators (Public Companies)

f. Key Ratios (Except Boston Scientific India Pvt. Ltd.)

g. Business Highlights (All Companies)

Buyer Details

1. Top 10 Hospitals Buying Coronary Stents In India

2. Buyer Profiles (All Companies)

a. Company Information (All Companies)

b. Products and Services (All Companies)

c. Key People (All Companies)

d. Business Highlights (All Companies)

e. Key Hospital Indicators

f. Stent Procurement Procedure

3. Other Major Hospitals Buying Coronary Stents In India

4.

Appendix

1. Key Ratios Description

2. Sources of Information

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Public Companies

1. Opto Circuits (India) Ltd.

Private Companies

1. Abbott Healthcare Pvt. Ltd.

2. B. Braun Medical (India) Pvt. Ltd.

3. Boston Scientific India Pvt. Ltd.

4. India Medtronic Pvt. Ltd.

5. MIV Therapeutics (India) Pvt. Ltd.

6. Meril Life Sciences Pvt. Ltd.

7. Relisys Medical Devices Ltd.

8. Sahajanand Medical Technologies Pvt. Ltd.

9. Vascular Concepts Ltd.

select a license
Corporate User License
USD 950 INR 65550

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com